An enforced gap analysis of technical documentation may show that current plastic resin grades or masterbatches do not have adequate change control, and there are insufficient change agreements with suppliers With a broad portfolio of healthcare polymer technologies under the Mevopur™ brand, Avient can assist in addressing many of these challenges. Learn more about Avient solutions for the healthcare market:

Get Help Now +1-866-737-2066 Pre-Color Enables $200K Savings Browse and download our literature to learn more about Avient solutions and services.

Office Supplies

Avient Color Prediction Service Chain Extender Additives ColorMatrix™ Select Rapid Color Creation and Supply

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...

DISCLAIMER STATEMENTS MSCI DISCLAIMER STATEMENT THE USE BY AVIENT CORPORATION OF ANY MSCI ESG RESEARCH LLC OR ITS AFFILIATES (“MSCI”) DATA, AND THE USE OF MSCI LOGOS, TRADEMARKS, SERVICE MARKS OR INDEX NAMES HEREIN, DO NOT CONSTITUTE A SPONSORSHIP, ENDORSEMENT, RECOMMENDATION, OR PROMOTION OF AVIENT CORPORATION BY MSCI. Such information and data are proprietary of Sustainalytics and/or its third party suppliers (Third Party Data) and are provided for informational purposes only. Scores can also indicate best-in class disclosure practices and save time in performing peer comparisons.

With Versaflex HC, on the other hand, injection molding happens in seconds, and does not require curing or washing, thus saving significant time and reducing cost.

Colors and special effects are incorporated with the goals of speed to market and cost savings in mind, to grow business and differentiate from competition. PRODUCT BULLETIN www.avient.com Copyright © 2020, Avient Corporation. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.

The company noted that GAAP EPS includes special items (Attachment 3) and intangible amortization expense (Attachment 1). # # 7 Investor Relations Contact: Giuseppe (Joe) Di Salvo Vice President, Treasurer and Investor Relations Avient Corporation +1 440-930-1921 giuseppe.disalvo@avient.com Media Contact: Kyle G. Rose Vice President, Corporate Communications Avient Corporation +1 440-930-3162 kyle.rose@avient.com 8 Attachment 1 Avient Corporation Summary of Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended December 31, Year Ended December 31, 2022 2021 2022 2021 Sales $ 790.4 $ 807.1 $ 3,396.9 $ 3,315.5 Operating Income 0.4 50.2 243.3 279.7 Net (loss) income from continuing operations attributable to Avient shareholders (17.0) 11.2 82.8 151.8 Diluted (loss) earnings per share from continuing operations attributable to Avient shareholders $ (0.19) $ 0.12 $ 0.90 $ 1.65 Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...